Apyx Medical Corporation

6.23+0.2100+3.49%Vol 315.42K1Y Perf -43.37%
Jun 28th, 2022 16:00 DELAYED
BID5.82 ASK6.72
Open5.86 Previous Close6.02
Pre-Market- After-Market6.23
 - -  - -%
Target Price
10.67 
Analyst Rating
Strong Buy 1.00
Potential %
71.27 
Finscreener Ranking
★★★★     54.30
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     52.72
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+     53.41
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
22.22 
Earnings Rating
Strong Sell
Market Cap214.77M 
Earnings Date
11th Aug 2022
Alpha0.03 Standard Deviation0.21
Beta1.13 

Today's Price Range

5.816.29

52W Range

3.0117.50

5 Year PE Ratio Range

-18.605.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
7.69%
1 Month
-3.99%
3 Months
-3.99%
6 Months
-51.61%
1 Year
-43.37%
3 Years
-10.42%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
APYX6.230.21003.49
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Financial StrengthValueIndustryS&P 500US Markets
4.00
4.70
0.00
0.00
-1 133.20
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
68.70
-30.30
-28.60
-48.90
-31.21
RevenueValueIndustryS&P 500US Markets
52.37M
1.52
20.62
2.71
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.13-0.17-30.77
Q04 2021-0.13-0.0653.85
Q03 2021-0.15-0.1220.00
Q02 2021-0.14-0.1214.29
Q01 2021-0.14-0.140.00
Q04 2020-0.13-0.0469.23
Q03 2020-0.16-0.1318.75
Q02 2020-0.17-0.1417.65
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.20-53.85Negative
9/2022 QR-0.14-16.67Negative
12/2022 FY-0.58-20.83Negative
12/2023 FY-0.3618.18Positive
Next Report Date11th Aug 2022
Estimated EPS Next Report-0.20
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume315.42K
Shares Outstanding34.47K
Shares Float33.32M
Trades Count3.86K
Dollar Volume1.94M
Avg. Volume744.17K
Avg. Weekly Volume881.41K
Avg. Monthly Volume591.12K
Avg. Quarterly Volume759.97K

Apyx Medical Corporation (NASDAQ: APYX) stock closed at 6.02 per share at the end of the most recent trading day (a 1.18% change compared to the prior day closing price) with a volume of 202.15K shares and market capitalization of 214.77M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 266 people. Apyx Medical Corporation CEO is Charles D. Goodwin.

The one-year performance of Apyx Medical Corporation stock is -43.37%, while year-to-date (YTD) performance is -53.04%. APYX stock has a five-year performance of %. Its 52-week range is between 3.01 and 17.5, which gives APYX stock a 52-week price range ratio of 22.22%

Apyx Medical Corporation currently has a PE ratio of -12.70, a price-to-book (PB) ratio of 4.14, a price-to-sale (PS) ratio of 3.96, a price to cashflow ratio of 133.80, a PEG ratio of 2.32, a ROA of -24.92%, a ROC of -29.38% and a ROE of -30.52%. The company’s profit margin is -31.21%, its EBITDA margin is -28.60%, and its revenue ttm is $52.37 Million , which makes it $1.52 revenue per share.

Of the last four earnings reports from Apyx Medical Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.20 for the next earnings report. Apyx Medical Corporation’s next earnings report date is 11th Aug 2022.

The consensus rating of Wall Street analysts for Apyx Medical Corporation is Strong Buy (1), with a target price of $10.67, which is +71.27% compared to the current price. The earnings rating for Apyx Medical Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Apyx Medical Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Apyx Medical Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.77, ATR14 : 0.58, CCI20 : -53.50, Chaikin Money Flow : 0.07, MACD : 0.25, Money Flow Index : 72.50, ROC : -15.45, RSI : 54.71, STOCH (14,3) : 27.32, STOCH RSI : 0.78, UO : 48.61, Williams %R : -72.68), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Apyx Medical Corporation in the last 12-months were: Craig A. Swandal (Option Excercise at a value of $84 660), Lawrence J. Waldman (Option Excercise at a value of $22 320), Michael Geraghty (Option Excercise at a value of $16 740)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (33.33 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.33

Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. The company's product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives majority revenue.

CEO: Charles D. Goodwin

Telephone: +1 727 384-2323

Address: 5115 Ulmerton Road, Clearwater 33760, FL, US

Number of employees: 266

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

70%30%

Bearish Bullish

71%29%

Bearish Bullish

61%39%

TipRanks News for APYX

Thu, 13 Jan 2022 05:25 GMT Analysts Are Bullish on These Healthcare Stocks: Apyx Medical (APYX), Incyte (INCY)

- TipRanks. All rights reserved.

News

Stocktwits